Skip to main content
رجوع
Watch Compare

Akebia Therapeutics, Inc.

جودة البيانات: 100%
AKBA
Nasdaq Manufacturing Chemicals
KWD 1.42
▼ KWD 0.02 (-1.05%)
القيمة السوقية: 379.05 M
السعر
KWD 1.42
القيمة السوقية
379.05 M
نطاق اليوم
KWD 1.41 — KWD 1.45
نطاق 52 أسبوعًا
KWD 1.14 — KWD 4.08
حجم التداول
782,462
فتح KWD 1.42
متوسط 50 يوم / 200 يوم
KWD 1.36
4.26% above
متوسط 50 يوم / 200 يوم
KWD 2.32
39.02% below

Quick Summary

النقاط الرئيسية

Revenue grew 2.55% annually over 5 years — modest growth
Generating 67.70 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 44.91%
Capital efficient — spends only 0.12% of revenue on capex

النمو

Revenue Growth (5Y)
2.55%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)47.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-15.10%
أعلى من متوسط القطاع (-53.41%)
ROIC8.11%
Net Margin-2.26%
Op. Margin9.95%

الأمان

Debt / Equity
1.15
أعلى من متوسط القطاع (0.31)
Current Ratio1.94
Interest CoverageN/A

التقييم

PE (TTM)
-70.92
أقل من متوسط القطاع (-1.48)
P/B Ratio9.11
EV/EBITDA11.07
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -70.9 -1.5
P/B 9.1 1.6
ROE % -15.1 -53.4
Net Margin % -2.3 -41.5
Rev Growth 5Y % 2.6 1.8
D/E 1.2 0.3

ETFs Holding This Stock

FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0.27% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.12% weight
LABU logo LABU Direxion Daily S&P Biotech Bull 3X ETF
0.07% weight
FAD logo FAD First Trust Multi Cap Growth AlphaDEX Fund
0.04% weight
ISCB logo ISCB iShares Morningstar Small-Cap ETF
0.02% weight
GSXPX GSXPX
0.01% weight
GTTTX GTTTX
0.01% weight
GTTUX GTTUX
0.01% weight
GSATX GSATX
0.01% weight
GSCTX GSCTX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 47.46% Revenue Growth (3Y) 10.16%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 2.55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 236.20 M Net Income (TTM) -5.35 M
ROE -15.10% ROA -1.51%
Gross Margin N/A Operating Margin 9.95%
Net Margin -2.26% Free Cash Flow (TTM) 67.70 M
ROIC 8.11% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.15 Current Ratio 1.94
Interest Coverage N/A Asset Turnover 0.67
Working Capital 124.96 M Tangible Book Value -17.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -70.92 Forward P/E N/A
P/B Ratio 9.11 P/S Ratio 1.60
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 11.07 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 17.86%
Market Cap 379.05 M Enterprise Value 260.25 M
Per Share
EPS (Diluted TTM) -0.02 Revenue / Share 0.88
FCF / Share 0.25 OCF / Share 0.25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.12% FCF Conversion -1266.62%
SBC-Adj. FCF 57.97 M Growth Momentum 44.91

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 236.20 M 160.18 M 194.62 M 292.60 M 213.58 M
Net Income -5.35 M -69.41 M -51.93 M -92.56 M -282.84 M
EPS (Diluted) -0.02 -0.33 -0.28 -0.51 -1.70
Gross Profit — — — — —
Operating Income 23.50 M -50.47 M -46.26 M -79.12 M -265.32 M
EBITDA — — — — —
R&D Expenses 62.36 M 37.65 M 63.08 M 129.11 M 147.85 M
SG&A Expenses 107.48 M 106.55 M 100.23 M 138.70 M 174.16 M
D&A — — — 1.65 M 1.93 M
Interest Expense — — — — —
Income Tax 1.62 M — — 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 376.57 M 220.67 M 241.70 M 351.83 M 525.55 M
Total Liabilities 343.96 M 269.86 M 272.29 M 342.49 M 449.09 M
Shareholders' Equity 32.61 M -49.19 M -30.58 M 9.34 M 76.46 M
Total Debt 48.25 M 38.69 M 34.68 M 66.08 M 97.54 M
Cash & Equivalents 184.84 M 51.87 M 42.93 M 90.47 M 149.80 M
Current Assets 252.96 M 113.83 M 118.15 M 184.95 M 272.01 M
Current Liabilities 162.94 M 80.91 M 99.87 M 124.76 M 256.49 M